-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Are Transplant Indications Changing for Myelofibrosis?

Program: Education Program
Session: What Are the Advances in Myeloproliferative Neoplasms Affecting Management?
Hematology Disease Topics & Pathways:
Biological therapies, Clinical Practice (Health Services and Quality), Therapies, Transplantation
Sunday, December 10, 2023, 9:30 AM-10:45 AM

Jeanne Palmer, MD

Mayo Clinic - Arizona, Phoenix, AZ

Disclosures: Palmer: Jubliant: Consultancy; Incyte: Consultancy, Other: Money went to the institution; morphosys: Consultancy, Other: Money went to institution; Sierra Oncology: Consultancy, Other: Money went to Institution; CTI BioPharma Corp.: Consultancy, Honoraria, Other: Money went to institution.

<< Previous Presentation | Next Presentation